Social Media

A drug that can extend the lives of some women with an advanced form of breast cancer has been rejected for use by National Health Service because it is too expensive. The high price of Kadcyla makes it "impossible" to recommend for widespread use in the health service, the National…
The UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated, thanks to a package of investment worth more than £300 million, the Prime Minister will announce today. The 4 year project will allow…
From September 2014 a new module will be available from the Cancer Education Team at Edinburgh Napier University (ENU). The course 'Supporting patients living with and beyond cancer' was developed in response to the views of professionals working with individuals and families living with and beyond cancer; current policy and…
People in the UK are grossly misinformed about breast cancer survival and fail to realise how poor it is compared with other countries, according to a leading charity. Only a quarter of those questioned in a nationwide survey knew that the UK's five-year survival rate is below the European average,…
A pilot project to test new ways of measuring cancer waiting times in Wales are underway, the Welsh Government has announced. A single cancer pathway will be piloted, measured and compared against the existing system. Currently, patients are placed on one of two pathways – a 62-day ‘urgent’ pathway or…
Too many cancer patients are being shown a "lack of compassion" by healthcare workers, a charity said. A fifth of cancer patients said they felt like a "set of symptoms" rather than a person, according to Macmillan Cancer Support. Meanwhile 17% of patients said their doctor spoke to them as…
A "tipping point" has been reached in the war against cancer with half of newly diagnosed patients in England and Wales surviving at least 10 years, a landmark study has shown. Many, though not all, of these patients will be no more at risk of dying than members of the…
Adverts for a pancreatic cancer charity that featured sufferers saying they would rather have a different form of the disease have been cleared following 121 complaints. The three press ads for Pancreatic Cancer Action stated: "Today, 23 people will be told they have pancreatic cancer...Only 3% will survive because of…
A new drug for breast cancer which extends women's lives by almost six months is to be blocked from routine NHS access under draft guidance issued by a health watchdog. Kadcyla, manufactured by Roche, can cost more than £90,000 per patient and is not effective enough to justify the price…
The way hospitals record deaths could be covering up poor treatment and costing lives, according to a new report. Figures show a dramatic rise in the number of people recorded as needing palliative care at the end of their lives, with some hospitals saying more than 35% of their patients…
Older people are being denied proper access to cancer care, an academic has claimed. A high proportion of older women with a certain form of breast cancer receive less chemotherapy than their younger counterparts, Professor Mark Lawler from Queen’s University Belfast said. More than 70% of deaths caused by prostate…
The first regional centre of excellence in the fight against prostate cancer is to be established by Queen’s University Belfast. A total of £5 million will be invested over five years on the collaboration between researchers in Belfast and Manchester. Prostate is the most common cancer among men, with 40,000…
Page 22 of 22